New advances in ovulation induction

Kafy, Souzan; Tulandi, Togas

doi:10.1097/gco.0b013e3280c60c9a

Cited by 38 publications

(15 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In case of resistance to CC, a low-dose ovarian stimulation regimen with gonadotrophins aimed at monofollicular growth is advisable, although this medication is more expensive. Alternatively, the use of aromatase inhibitors (AI) such as anastrozole and letrozole may be considered (Begum et al ., 2006; Verpoest et al ., 2006; Casper, 2007; Kafy and Tulandi, 2007). Although more expensive than CC, success rates may be slightly higher when compared with CC, probably due to a better endometrial, receptivity (Atay et al ., 2006).…”

Section: Suggested Strategies For Affordable Infertility Management Imentioning

confidence: 99%

Infertility and the provision of infertility medical services in developing countries

Ombelet

Cooke²,

Dyer

et al. 2008

Human Reproduction Update

530

398

View full text Add to dashboard Cite

BACKGROUNDWorldwide more than 70 million couples suffer from infertility, the majority being residents of developing countries. Negative consequences of childlessness are experienced to a greater degree in developing countries when compared with Western societies. Bilateral tubal occlusion due to sexually transmitted diseases and pregnancy-related infections is the most common cause of infertility in developing countries, a condition that is potentially treatable with assisted reproductive technologies (ART). New reproductive technologies are either unavailable or very costly in developing countries. This review provides a comprehensive survey of all important papers on the issue of infertility in developing countries.METHODSMedline, PubMed, Excerpta Medica and EMBASE searches identified relevant papers published between 1978 and 2007 and the keywords used were the combinations of ‘affordable, assisted reproduction, ART, developing countries, health services, infertility, IVF, simplified methods, traditional health care'.RESULTSThe exact prevalence of infertility in developing countries is unknown due to a lack of registration and well-performed studies. On the other hand, the implementation of appropriate infertility treatment is currently not a main goal for most international non-profit organizations. Keystones in the successful implementation of infertility care in low-resource settings include simplification of diagnostic and ART procedures, minimizing the complication rate of interventions, providing training-courses for health-care workers and incorporating infertility treatment into sexual and reproductive health-care programmes.CONCLUSIONSAlthough recognizing the importance of education and prevention, we believe that for the reasons of social justice, infertility treatment in developing countries requires greater attention at National and International levels.

show abstract

Section: Suggested Strategies For Affordable Infertility Management Imentioning

confidence: 99%

Infertility and the provision of infertility medical services in developing countries

Ombelet

Cooke²,

Dyer

et al. 2008

Human Reproduction Update

530

398

View full text Add to dashboard Cite

show abstract

“…Clomiphene citrate has been used as a first-line ovulation induction agent for over 40 years [20,21]. It is a selective estrogen receptor modulator that stimulates endogenous FSH production and Key to evidence statements and grading of recommendations, using the ranking of the Canadian Task Force on Preventive Health Care.…”

Section: Clomiphene Citratementioning

confidence: 99%

Ovulation Induction in Polycystic Ovary Syndrome

Vause

Cheung

Sierra

et al. 2010

Intl J Gynecology & Obste

View full text Add to dashboard Cite

show abstract

“…Aromatase inhibitors block the aromatase enzyme, which suppresses estrogen production (6). Because aromatase inhibitors do not disrupt estrogen binding, the deleterious effects associated with CC may be avoided (7).…”

mentioning

confidence: 99%

Anastrozole single-dose protocol in women with oligo- or anovulatory infertility: results of a randomized phase II dose–response study

Tredway

Schertz

Bock

et al. 2011

Fertility and Sterility

View full text Add to dashboard Cite

New advances in ovulation induction

Abstract: Aromatase inhibitors are alternative drugs to clomiphene or gonadotropin for ovulation induction or superovulation.

Cited by 38 publications

References 29 publications

Infertility and the provision of infertility medical services in developing countries

Infertility and the provision of infertility medical services in developing countries

Ovulation Induction in Polycystic Ovary Syndrome

Anastrozole single-dose protocol in women with oligo- or anovulatory infertility: results of a randomized phase II dose–response study

Contact Info

Product

Resources

About